- Home
- MXL vs ARDX Comparison
MXL vs ARDX Comparison
Compare MXL & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MXL
- ARDX
- Stock Information
- Founded
- MXL 2003
- ARDX 2007
- Country
- MXL United States
- ARDX United States
- Employees
- MXL N/A
- ARDX N/A
- Industry
- MXL Semiconductors
- ARDX Biotechnology: Pharmaceutical Preparations
- Sector
- MXL Technology
- ARDX Health Care
- Exchange
- MXL Nasdaq
- ARDX Nasdaq
- Market Cap
- MXL 1.1B
- ARDX 1.3B
- IPO Year
- MXL 2010
- ARDX 2014
- Fundamental
- Price
- MXL $10.86
- ARDX $4.91
- Analyst Decision
- MXL Buy
- ARDX Strong Buy
- Analyst Count
- MXL 7
- ARDX 9
- Target Price
- MXL $25.58
- ARDX $10.61
- AVG Volume (30 Days)
- MXL 1.5M
- ARDX 3.8M
- Earning Date
- MXL 04-23-2025
- ARDX 05-01-2025
- Dividend Yield
- MXL N/A
- ARDX N/A
- EPS Growth
- MXL N/A
- ARDX N/A
- EPS
- MXL N/A
- ARDX N/A
- Revenue
- MXL $360,528,000.00
- ARDX $333,615,000.00
- Revenue This Year
- MXL $24.50
- ARDX $14.26
- Revenue Next Year
- MXL $19.87
- ARDX $32.49
- P/E Ratio
- MXL N/A
- ARDX N/A
- Revenue Growth
- MXL N/A
- ARDX 168.06
- 52 Week Low
- MXL $10.21
- ARDX $4.32
- 52 Week High
- MXL $26.59
- ARDX $9.33
- Technical
- Relative Strength Index (RSI)
- MXL 31.10
- ARDX 39.95
- Support Level
- MXL $12.40
- ARDX $5.00
- Resistance Level
- MXL $13.50
- ARDX $5.56
- Average True Range (ATR)
- MXL 0.60
- ARDX 0.26
- MACD
- MXL 0.01
- ARDX -0.05
- Stochastic Oscillator
- MXL 19.76
- ARDX 22.27
About MXL MaxLinear Inc.
MaxLinear Inc is a provider of radio frequency and mixed-signal integrated circuits for cable and satellite broadband communications, the connected home, and for data center, metro, and long-haul fiber networks. The company's radio frequency receiver products capture and process digital and analog broadband signals to be decoded for various applications. Its product options include both radio frequency receivers and radio frequency receiver systems-on-chips. The company's products enable the distribution and display of broadband video and data content in a wide range of electronic devices.
About ARDX Ardelyx Inc.
Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative, first-in-class medicines that meet significant unmet medical needs. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.